Objective: The aim of the paper was to describe the relationship of the anatomical and electrophysiological target for the subthalamic electrode implantation in Parkinson's disease patients defi ned as the best electrophysiological recordings from multiple paralel electrodes tracts with a target discrepancy explanation. Background: Although microrecording is the standard in subthalamic stimulation, microelectrode monitoring prolongs surgical time and may increase the risk of haemorrhagic complications. The main purpose for the electrophysiological mapping is to overcome the discrepancy between the anatomical and electrophysiological targets. Methods: Subthalamic electrodes were stereotactically implanted in 58 patients using microrecording by means of parallel electrodes at defi ned distances. The relationship of the fi nal electrode to the anatomical trajectory, the subthalamic nucleus electrical activity length, and the relationship of right and left electrodes were analysed. Results: The fi nal electrode placement matched the anatomical trajectory in 53.4 % of patients on the right side, and 43.1 % of patients on the left side. The electrode position was symmetrical in 38.3 % of patients. The analysis of left and right electrode positions did not prove brain shift as the sole factor responsible for anatomyfunctional discrepancy. Further, neither age, Parkinson's disease duration, or L-DOPA adverse effects were confi rmed as responsible factors.
Both direct and indirect targeting techniques can be used for deep brain stimulation electrode implantation into the subthalamic nucleus in Parkinson's disease patients. The principle of indirect subthalamic nucleus targeting utilises the known spatial relationship of the surgical target and the intercommissural line or structures that can be easily visualised (e.g. red nucleus for subthalamic electrode targeting). The direct targeting technique relies on direct visualisation of the target structure (1, 2) .
The results of anatomical targeting can be supported by electrophysiological techniques that include monitoring the target and its surroundings and stimulation in order to verify the target structure. The use of micromonitoring techniques is well established and typical recordings of subthalamic electrophysiological activity as recorded by microelectrodes support the use of electrophysiological recordings in subthalamic stimulation. According to a survey of North American centres implanting deep brain stimulation (DBS) electrodes, microelectrode monitoring was used in 97 % of the participating centres (3) . However, the overall review of literature conducted by Hariz revealed that microelectrode monitoring does not necessarily improve the clinical outcome or targeting results in comparison with macrostimulation or impedance monitoring (4) . Microelectrode monitoring may also prolong the length of surgery. The risk of haemorrhagic complications caused by multiple penetration of microelectrodes (simultaneous or sequential) cannot be ignored (5, 6, 7) . The risk of haemorrhage is reported to be higher for pallidal (6.7 %) than subthalamic (2.7 %) surgeries (8) . Papers presenting excellent surgical outcomes without electrophysiological monitoring should also be considered (9) , including data published about deep brain electrode implantation in interventional MRI without electrophysiological monitoring (10) .
More or less sophisticated techniques are used to defi ne the relationship between the fi nal target structures selected by electrophysiological techniques and the anatomically-defi ned target. The distance between the anatomical target and the fi nal target can be defi ned as the difference between the target structure and the optimum contact position in x,y,z coordinates or as a scalar or vector distance between the optimum contact position and the planned target (2, 11) . A more simple technique of anatomical and functional target analysis is based on the fact that systems enabling monitoring electrode implantation (e.g. MicroDrive) in parallel directions in defi ned interelectrode distances are used for microelectrode monitoring and fi nal electrode implantation. The result of the intraoperative electrophysiological monitoring performed with this system is defi ned as the optimum trajectory as related to system ports for electrode implantation and the length of subthalamic nucleus electrophysiological recordings. Although the technique may look oversimplifi ed for statistical studies, the relationship between the anatomical target and the electrophysiological target can be studied and the cause of possible differences can be defi ned.
Methods
Between 2003 and 2009, 59 patients (39 males, 19 females) suffering from motor complications of advanced Parkinson's disease underwent implantation of 117 subthalamic DBS electrodes (Tab. 1). With the exception of one patient (a 59-year-old male with transient cognitive disturbance and predominantly unilateral problems), all patients underwent bilateral implantation.
A ceramic MRI-compatible Leibinger stereotactic frame was attached to the patient's head under a local anaesthesia on the morning of surgery. A combination of direct and indirect techniques was used to defi ne the subthalamic nucleus coordinates. The imaging protocol include T2-weighted fat-saturation study in the axial and coronal planes, MRI angiography (arterial and venous phase), and 3D gradient echo multiplanar reconstruction T1-weighted image (WI) after a contrast administration. The image sets were merged in a dedicated computer planning workstation using stereotactic planning software (Praezis Plus, Tatramed, Slovakia). The initial coordinates for the subthalamic nucleus (dorsolateral) were then determined in reference to the anterior commissure-posterior commissure (AC-PC) line (intercommissural line) using an indirect technique, typically 11 mm lateral, 3 mm posterior, and 5 mm ventral to the intercommissural point. The fi nal target coordinates were then modifi ed with respect to direct visualisation of the subthalamic nucleus on T2-WI and in relations to the red nucleus anterior margin and the largest red nucleus cross-sectional area. The distance from the red nucleus centre can be also considered (approximately 3.5 to 4 mm in front of the centre of the red nucleus and 6.5 mm laterally). A particular attention was paid to the posterior cerebral artery and its branches during target and trajectory planning, because the vessels may form loops, especially in patients of advanced age, and prevent safe electrode implantation. Similar attention was paid to intraventricular veins and cortical vessels.
The intraoperative microelectrode recording together with the intraoperative stimulation using the MicroDrive system were used to confi rm the results of anatomical targeting. The principle of the MicroDrive system is the simultaneous implantation of up to 5 parallel microelectrodes in defi ned positions related to a central trajectory (anatomical trajectory), marked anterior (2.5 mm anterior to the central trajectory), lateral (2.5 mm lateral to the central trajectory), medial (2.5 mm medial to the central trajectory) and posterior (2.5 mm posterior to the central trajectory). For subthalamic electrode implantation, a combination of central, anterior, lateral, and posterior electrodes was used in all patients for the intraoperative microelectrode recording. Microelectrode recording was started 10 mm above the anatomical target and microelectrodes were advanced in 1 mm steps until 5 mm above the anatomical target (0.5 mm steps). The subthalamic activity was recorded for each electrode. The length of the subthalamic nucleus was defi ned as the distance between the points where the subthalamic activity was fi rst recorded to the end of recorded subthalamic activity for each side.
The motor part of the subthalamic nucleus was identifi ed by recording the pattern of neuronal activity, background activity, and motor responsiveness (changes in neuronal fi ring in response to passive and active manipulation of contralateral limbs during the perioperative microrecording). We determined the dorsolateral border of the subthalamic nucleus by the microelectrode recording of cellular fi ring patterns. We also assessed the lead location by evaluating the symptom response to the intraoperative microstimulation.
After the completion of microelectrode monitoring, the intraoperative stimulation by means of the electrodes with the best microelectrode recording was performed, and the effect of stimulation on rigidity, tremor, and bradykinesis was monitored. Because these changes might not be apparent when observed intraoperatively, another purpose of the intraoperative stimulation is to identify possible adverse events, such as speech changes, paresthesia (transient paresthesias do not contraindicate electrode implantation because their cause may be the stimulation of the posterior subthalamus) and eye deviation (conjugate deviation caused by corticospinal tract stimulation, and dysconjugate deviation caused by oculomotor nucleus stimulation). Elicitation of dyskinesia by the intraoperative stimulation of the subthalamic nucleus area can also be assessed.
The Zamorano-Dujovny stereotactic system was used for electrode implantation in all patients, and the right-sided electrode was the fi rst electrode implanted in all patients.
Fluoroscopic images were taken at the moment of microelectrode guiding tube implantation, before the start of monitoring and during a defi nitive electrode implantation to exclude any deviation of the electrode guiding tubes and electrodes. The fi nal lead position was verifi ed by postoperative stereotactic CT, which also aimed to exclude postoperative complications.
Results
There was no symptomatic intracerebral haematoma requiring surgical intervention. One asymptomatic small subcortical haematoma (1.5 cm) immediately beneath the trephination opening was found on a postoperative CT in one asymptomatic patient. The position of the implanted electrode as defi ned by the MicroDrive parallel trajectories is presented in the Table 2 . In all patients, the fi nal electrode matched the trajectory with the longest recorded subthalamic activity. On the right side, the fi nal electrode was implanted in the central position in 53.4 % of patients. On the left side, the percentage of central electrodes was 43.1 %. However, the difference of electrode percentages implanted in individual positions does not reach the level of statistical signifi cance (Fischer exact test), not only for central (anatomical trajectory) but also for other electrode trajectories (posterior, anterior, and lateral).The position of implanted electrodes was symmetrical in 38.3 % of patients and asymmetrical in 61.7 % of patients. Although the intraoperative stimulation was performed in all our patients, the results of the intraoperative stimulation did not alter the fi nal electrode trajectory. Table 3 compares the positions of defi nite electrodes implanted on the right (fi rst implanted) and left sides (implanted after a right-sided surgery) in the plane perpendicular to the long axis of the MicroDrive system. Table 4 presents the length of recorded subthalamic nucleus activity for right and left sides.
The length of the recorded subthalamic activity in the central electrode was 2 to 5 mm (median 3 mm) on the right side and 2 to 6 mm (median 3.5 mm) on the left side. In patients with implanted other than central electrode, the length of subthalamic activity was 2 to 6 mm (median 4 mm) on the right side and 2 to 7 mm (median 4 mm) on the left side. For left subthalamic electrodes, a statistical evaluation did not prove a difference of subthalamic activity length between the central electrodes and other electrode locations. In right subthalamic electrodes, the statistical evaluation proved a signifi cantly longer subthalamic activity in other than the central electrode locations (Tab. 5).
The patient age, duration of Parkinson's disease, and L-DO-PA treatment adverse effects were compared between the group of patients with implanted central electrodes and the group with other defi nitive electrode locations. A statistical evaluation did not confi rm a signifi cant difference between the ages of patients with central electrodes and patients with non-central electrodes implanted for both right and left electrode. Similarly, a statistical evaluation did not confi rm a longer duration of Parkinson's disease or L-DOPA treatment adverse effects in the patients with non-central electrodes implanted for both sides (Tab. 6). Left The posterior trajectory was the second most frequently implanted after the central-anatomical trajectory. The results of statistical analysis comparing the patient age and Parkinson's disease duration between patients with central or posterior electrodes did not confi rm a signifi cant difference between the groups. However, a statistical analysis confi rmed a signifi cantly longer subthalamic nucleus recording in patients with the posterior right -sided electrodes than in patients with the central right-sided electrodes (Tab. 7).
Discussion
The need for the intraoperative electrophysiological monitoring is strongly supported by the difference between the anatomical target structure and the fi nal target structure as defi ned by the electrophysiological intraoperative microrecording and macrostimulation, not only in subthalamic stimulation.
For instance, the paper published by Foerster et al. showed that the electrophysiological monitoring (microelectrode monitoring, evoked potentials, and macrostimulation) modifi ed the surgery in 67 % of cases (mainly thalamic targets), but the authors declared that more sophisticated planning techniques resulted in a better correlation between the anatomical and electrophysiological targets (12) .
Recently, in a group of 42 patients operated on for dystonia (pallidal stimulation), Pinsker implanted the central-anatomical electrode in 64 % of the patients, even when the target structure was defi ned using stereotactic T2 or inversion recovery MRI. The medial trajectory was optimal in 20 % of the patients; the anterior in 9 %, and the lateral with posterior trajectories in 3.5 % each [13] .
A similar technique comparing the anatomical target and fi nal electrode target as defi ned by microelectrode recording was used in the Amirnovin's study of a group of 70 subthalamic electrodes implanted in 40 patients with a target confi rmation using intraoperative monitoring. Although the system used for the electrode implantation and intraoperative monitoring was not MicroDrive (3 parallel ports for microelectrodes and fi nal electrodes 2 mm apart), the results are comparable. Their results showed a slightly increased incidence of intracerebral haematomas (4 out of 40 patients). The frequency of electrode trajectories used for fi nal electrode implantation was anterior 29 %, central-anatomical 42 %, and 29 % posterior on the right side; and anterior 35 %, central-anatomical 39 %, and 26 % posterior on the left side. Interestingly, the authors began with the left electrode in bilateral surgeries. The percentage of the central-anatomical electrodes did not differ between the left and right sides, although there was a tendency towards a lower percentage of anatomical electrodes on the fi rst implanted left side (14) . On the other hand, in the paper by Hamid et al, the authors found it easier to defi ne the subthalamic nucleus electrical activity on the side fi rst operated on, although their monitoring technique was different (not using simultaneous implantations of several parallel electrodes; when the recording obtained was not satisfactory, the electrode was removed and reinserted 2 mm from the initial target) (15) .
Similarly, Bour implanted the anatomical-central electrode in 50 % of patients with subthalamic nucleus stimulation. In 64 % of the cases, the channel selected for the permanent electrode implantation corresponded with the trajectory with the longest recorded subthalamic activity. The subthalamic microrecording was considered to be the indicator of the best electrode for the intraoperative macrostimulation and the fi nal electrode implantation. Similar data were obtained for pallidal surgeries (16) . Brain shift may be one possible explanation for the difference between the anatomical target structure and the fi nal target for electrode implantation as adjusted according to the results of the electrophysiological monitoring. However, other causes of the difference between the anatomical target and the fi nal electrode placement may include the degree of target determination accuracy (the difference between the target locations using different targeting methods) (11) , MRI image distortion (15) , technical aspects of electrode implantation, and interindividual variants of subthalamic nucleus shape and size. The anatomical position of the subthalamic nucleus may not strictly follow the AC-PC line due to its complex embryological origin. Its medial part derives from the lateral hypothalamus, whereas the lateral part is linked to the development of the pallidum (17) . More recently, important genetic factors playing role in the development of Parkinson´s disease were recognised (18) . However, the association between the identifi ed genetic factors and intraoperative fi ndings was not described so far. In a study evaluating the variability of the subthalamic nucleus and the coordinates of its centre, Daniluk et al. showed that the subthalamic nucleus lateral coordinate ranged from 8.7 to 14.5 mm, the anteroposterior coordinate from 3.5 mm posterior to 0.5 mm anterior, and the vertical coordinate from 1.3 to 6 mm below the midcommissural point. The lateral coordinate strongly correlated with the width of the third ventricle (19) .
Nunta-aree et al. compared four different targeting techniques for the subthalamic nucleus, with the average of the fi nal lead position of each technique used to determine an appropriate AC-PC based formula for the subthalamic nucleus in Thai patients. The appropriate formula was 11.5 mm lateral, 3.5 mm posterior, and 5.0 mm inferior to the mid-commissural point, which only slightly differed from the initial target coordinates used for the subthalamic nucleus targeting in our patients (20) .
Brain shift may occur any time between imaging study acquisition and fthe inal electrode implantation. The cause of brain shift or brain sink may not be only the loss of cerebrospinal fl uid with resulting pneumocephalus, but also the gravitational movements of brain tissue depending on head position (for instance, planning data acquisition taking place in a different position than the surgical position, i.e., patient lying fl at versus slight head elevation). Brain tissue movements may also be caused by brain deformation during temporary or fi nal electrode implantation (21) .
Because indirect techniques of subthalamic nucleus targeting employ the relationship between the target structure and the intercommissural line, the problem of the commissural shift during stereotactic surgery has been discussed by many authors.
Miyagi et al proved a higher degree of AC-PC shifts in patients with bilateral implants than in patients with unilateral implants: 2.2 mm (SD -Standard Deviation -0.9 mm) median AC shift in bilateral implants and 1.2 mm (SD 0.9 mm) median shift of AC in unilateral implants. The median value of the PC shift was lower: 0.7 mm (SD 0.6 mm) in unilateral implants and 1.0 mm (SD 0.9 mm) in bilateral implants. The difference was explained by air entering the subdural space with a resulting brain shift. Air entry after the fi rst electrode implantation should result in a contralateral brain shift. After the contralateral trephination for the second electrode implantation, shift equilibrium is established because of air entry from the contralateral side (22) . However, the support by the contralateral hemisphere is lost and a signifi cant caudal brain shift occurs. When applying their conclusions to data describing the fi nal electrode location, the lateral and posterior fi nal electrode targets resulting from posterior or lateral electrode shifts should prevail in left-sided, rather than right-sided, electrodes. This assumption was not confi rmed, although there was some tendency for a larger percentage of lateral electrodes on the left side.
In the study by Elias, the extent of commissural shift was higher than in the Miyagi study, varying between -5.6 to 1 mm for AC and -1.7 to 0.5 mm for PC. The authors found a signifi cant correlation between the extent of postoperative pneumocephalus and AC shift (23) . In Petersen´s paper, the AC-PC shift was less marked (AC -0.4±0.6 mm and PC -0.2±0.7 mm) (21).
Winkler et al studied the association between the degree of frontal cortex and subthalamic nucleus shift using a tissue deformation technique. A frontal cortex shift of -12 mm was associated with a 2 mm subthalamic nucleus shift. Morphological results were supported by microelectrode data (24) .
Because the right electrode was the fi rst to be implanted in all patients, the percentage of central trajectories was expected to be lower on the left side as the result of brain shift. Although the percentage of central trajectories was higher on the right side, the statistical evaluation did not prove a signifi cant difference. In the study by Amirnovin, the left-sided electrode was implanted fi rst, but the percentage of central electrodes was surprisingly slightly higher on the right side, at 42 %, than on the left side, at 39 % (14). Bour et al noted a non-signifi cant trend towards a less frequent choice for the central electrode on the side operated on second (right side). The authors attribute the difference to cerebrospinal fl uid loss and subdural air invasion with potential brain displacement.
Although the authors used a medial electrode port for monitoring, medial electrodes were implanted in only 6 % of the patients (16) .
If brain shift in a posterior direction, it is understood as the main cause of discrepancy between the planned and defi nitive electrode trajectory, a higher number of posterior trajectories and fewer anterior trajectories can be expected on the left side when compared to the side of the fi rst implanted electrode. This assumption was not confi rmed by the statistical evaluation. Therefore, the comparison of the fi nal electrode position on the right and left sides does not support the role of brain shift as the most important causative factor for the difference between the anatomical and electrophysiological targets.
The observation of different defi nitive positions was supported by the results of Patel. The authors observed marked variations in subthalamic nucleus size and orientation. A signifi cant difference was demonstrated when comparing left and right sided x and y coordinates. The same difference between right and left surgical trajectories observed in our study supported this data (25) .
Structural changes of the subthalamic nucleus caused by the natural course of progressive neurodegenerative disease can be considered as another cause of the discrepancy between the anatomical target and fi nal electrode placement. If this were true, a higher percentage of central-anatomical electrodes could be expected in younger patients and patients with shorter disease duration. However, no signifi cant difference in age and disease duration was proven when the group of patients in whom central electrodes were implanted was compared to patients with other than central electrode implanted. Although the duration of L-DOPA adverse effects may not refl ect the degree of degenerative disease progression, it should be noted that the statistical evaluation did not prove a signifi cant difference of L-DOPA adverse effect duration between patients with central and non-central electrode implanted.
Finally, the length of subthalamic nucleus recording was compared between the group of patients with central electrodes and patients with non-central electrode implanted. The length of subthalamic activity in our study was slightly lower than that presented by other authors (Hamid et al, 4 .65 mm; McClelland III et al, 4.5 mm) because of different methodologies for the subthalamic nucleus length determination and the use of medians in our study. The length of subthalamic activity may refl ect more than the activity of the motor subthalamus (association and limbic subthalamic parts are located in the lower subthalamic nucleus) and the length of the subthalamic nucleus may also correlate with the surgical trajectory angle (15, 26) .
The statistical analysis did not confi rm any difference in subthalamic nucleus activity length between the central-anatomical fi nal trajectory and other trajectories on the left side (implanted as second side), not supporting a possible role of brain shift in the difference between the anatomical and fi nal electrode targets. Surprisingly for right electrodes, the statistical evaluation proved a signifi cantly longer length of recorded subthalamic activity in non-central electrode locations.
Another important role of the electrophysiological monitoring is the intraoperative detection of surgical problems. The electrophysiological activity substantially differing from expected fi ndings should draw an attention to possible surgical problems that may occur before surgery (e.g. incorrect target structure choice), during preparatory phase (e.g. stereotactic frame setting error, stereotactic frame dislocation) and intraoperatively (e.g. marked brain shift, intracerebral bleeding with electrophysiological silence) (27) .
Data supporting the use of intraoperative monitoring, increasing a surgical invasiveness, should be confronted with possible surgical risks and benefi ts. The low incidence of haemorrhagic complications in our series (1.7 %) matches the data presented by other authors (5, 7), although the literature overview report by Hariz stated that microelectrode recordings were fi ve times more likely associated with haemorrhagic complication (4).
Conclusions
Although the study criteria analysing the relationship of the anatomical targets and targets defi ned with the use of the electrophysiological monitoring may look simple (MicroDrive trajectory, subthalamic nucleus activity length), it provides new insights into the determination of possible factors responsible for the differences between the anatomical and functional targets. The differences cannot be attributed only to brain shift. The possible roles of age, Parkinson's disease duration, and L-DOPA adverse effects were not confi rmed by the study results. Study results, together with a low incidence of haemorrhagic complications, provide the evidence supporting the use of the intraoperative microrecording for subthalamic electrode targeting.
